Ajanta Pharma Gets USFDA Approval For Migraine Pain Relief Drug

New Delhi: Ajanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US health regulator. "The company received the final approval for Zolmitriptan tablets (2.5 mg, 5 mg) from the US Food and Drug Administration (USFDA). Zolmitriptan is used in the acute treatment of migraine and is bio-equivalent generic version of Zomig," Ajanta Pharma said in a regulatory fi...